Wu-Pu Lin

ORCID: 0009-0004-9371-3305
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Nutrition and Health in Aging
  • Sepsis Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Drug-Induced Ocular Toxicity
  • Hematological disorders and diagnostics
  • SARS-CoV-2 and COVID-19 Research
  • Antibiotic Resistance in Bacteria
  • Pneumonia and Respiratory Infections
  • Liver physiology and pathology
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Cardiac tumors and thrombi
  • Soft tissue tumors and treatment
  • Central Venous Catheters and Hemodialysis
  • Liver Disease Diagnosis and Treatment
  • COVID-19 and Mental Health
  • Antibiotics Pharmacokinetics and Efficacy
  • Patient Satisfaction in Healthcare
  • Diet, Metabolism, and Disease
  • High Altitude and Hypoxia
  • Antibiotic Use and Resistance
  • Urinary Tract Infections Management
  • Respiratory Support and Mechanisms

Ministry of Health and Welfare
2019-2024

Taipei Hospital
2019-2024

Chinese People's Liberation Army
2021

National Taiwan University Hospital
2005-2019

Objective In this study, we evaluated the efficacy of hydroxychloroquine (HCQ) against coronavirus disease 2019 (COVID-19) via a randomized controlled trial (RCT) and retrospective study. Methods Subjects admitted to 11 designated public hospitals in Taiwan between April 1 May 31, 2020, with COVID-19 diagnosis confirmed by pharyngeal real-time RT-PCR for SARS-CoV-2, were at 2:1 ratio stratified mild or moderate illness. HCQ (400 mg twice d 200 daily 6 days) was administered. Both study...

10.1371/journal.pone.0242763 article EN cc-by PLoS ONE 2020-12-02
Cathrine Axfors Andreas M. Schmitt Perrine Janiaud Janneke van ‘t Hooft Sherief Abd‐Elsalam and 89 more Ehab F. Abdo Benjamin S. Abella Javed Akram Ravi K. Amaravadi Derek Angus Yaseen M. Arabi Shehnoor Azhar Lindsey R. Baden Arthur W. Baker Leïla Belkhir Thomas Benfield Marvin A. H. Berrevoets Cheng‐Pin Chen Tsung‐Chia Chen Shu‐Hsing Cheng Chien‐Yu Cheng Wei‐Sheng Chung Yehuda Z. Cohen Lisa N. Cowan Olav Dalgård Fernando Fonseca de Almeida e Val Marcus Lacerda Gisely Cardoso de Melo Lennie Derde Vincent Dubée Anissa Elfakir Anthony Gordon Carmen Margarita Hernández‐Cardenas Thomas Hills Andy I. M. Hoepelman Yi-Wen Huang Bruno Igau Ronghua Jin Felipe Jurado-Camacho Khalid S. Khan Peter G. Kremsner Benno Kreuels Cheng-Yu Kuo Thuy Le Yi‐Chun Lin Wu-Pu Lin Tse-Hung Lin Magnus Nakrem Lyngbakken Colin McArthur Bryan J. McVerry Patricia Meza-Meneses Wuelton Marcelo Monteiro Susan C. Morpeth Ahmad Mourad Mark J. Mulligan Srinivas Murthy Susanna Naggie Shanti Narayanasamy Alistair Nichol Lewis A. Novack Sean M. O’Brien Nwora Lance Okeke Léna Perez Rogelio Pérez‐Padilla Laurent Perrin Arantxa Remigio-Luna Norma E. Rivera-Martínez Frank W. Rockhold Sebastián Rodríguez‐Llamazares Robert Rolfe Rossana Rosa Helge Røsjø Vanderson de Souza Sampaio Todd B. Seto Muhammad Shehzad Shaimaa Soliman Jason E. Stout Ireri Thirión-Romero Andrea B. Troxel Ting-Yu Tseng Nicholas Turner Robert J. Ulrich Stephen R. Walsh Steve Webb Jesper M. Weehuizen Maria Velinova Hon-Lai Wong Rebekah Wrenn Fernando G. Zampieri Wu Zhong David Moher Steven N. Goodman John P. A. Ioannidis Lars G. Hemkens

Abstract Background Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aimed estimate the effects of hydroxychloroquine and chloroquine survival in from all available RCT evidence, published unpublished. Methods: Rapid meta-analysis ongoing, completed, discontinued RCTs treatment for any patients (protocol: https://osf.io/QESV4/ )....

10.1101/2020.09.16.20194571 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-09-18

Abstract Drug-resistant Klebsiella pneumoniae , especially extended-spectrum β-lactamase (ESBL)- and/or AmpC β-lactamase-producing strains, is an emerging problem worldwide. However, few data focusing on drug susceptibility of K. from community available. In this study, we analyzed 1016 isolates outpatients or those visiting emergency rooms collected during 2002–2012 Taiwan Surveillance Antimicrobial Resistance program. Significantly decreased susceptibilities to 3 rd generation...

10.1038/srep36280 article EN cc-by Scientific Reports 2016-11-08

An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the 'Save PDF' action button.

10.1017/s0950268825000172 article EN cc-by-nc-nd Epidemiology and Infection 2025-02-07

Increased resistance to third-generation cephalosporin (3GC) is a serious concern for community-onset Escherichia coli infection because this easily delays effective treatment. This study surveyed the current antimicrobial pattern among E. isolates that cause bacteremia, with special focus on prevalence of and risk factors 3GC resistance, determined poor outcomes patients bacteremia. retrospective was conducted at tertiary-care teaching hospital in Taiwan. All adult bacteremia between...

10.1186/s12879-019-3880-z article EN cc-by BMC Infectious Diseases 2019-03-12

Central line (CL)-associated bloodstream infection (CLABSI) poses a major threat to patient safety and is associated with additional cost. This study investigated the sustained effect of multimodal interventions focusing on CL bundle improvement in adult intensive care units (ICUs) teaching hospital Taiwan.A before-after prospective was conducted 17 ICUs medical center northern Taiwan from January 2009 December 2013. Many that aimed facilitate implementation were initiated 2011. The...

10.1016/j.jmii.2017.08.008 article EN cc-by-nc-nd Journal of Microbiology Immunology and Infection 2017-08-26

Abstract Objective In this study, we evaluated the efficacy of hydroxychloroquine (HCQ) against coronavirus disease 2019 (COVID-19) via a randomized controlled trial (RCT) and retrospective study. Methods Subjects admitted to 11 designated public hospitals in Taiwan between April 1 May 31, 2020, with COVID-19 diagnosis confirmed by pharyngeal real-time RT-PCR for SARS-CoV-2, were at 2:1 ratio stratified mild or moderate illness. HCQ 400 mg twice d 200 daily 6 days administered. Both study...

10.1101/2020.07.08.20148841 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-10

The morbidity and mortality that accompany fatty liver may occur as a result of increased apoptosis hepatocytes decreased regeneration. We determined the effects high-fiber diet on hepatocyte regeneration after partial hepatectomy in rats with liver.Fatty was induced male Wistar weighing around 200 g through feeding high-fat for 4 weeks. were then randomly assigned to 3 groups received diet, normal or another Partial (around 70%) performed, killed 6, 24, 48, 72 hours hepatectomy. measured...

10.1177/0148607105029006401 article EN Journal of Parenteral and Enteral Nutrition 2005-11-01
Coming Soon ...